Jump to Footer

Shusen Sun

Director of International Pharmacy Programs
Department of Pharmacy Practice

Email:     ssun@wne.edu
Phone:   413-796-2424
Office:    CSP 425

Dr. Sun was a research scientist at Pfizer prior to his pharmacy career, and received the Pfizer Global Research and Development Excellence Award in 2002 and Discovery Above and Beyond Award in 2005.  He received his PharmD from Creighton University and is a Board Certified Pharmacotherapy Specialist. He has ten years of experience as a clinical pharmacy specialist providing direct patient care in emergency departments. He established comprehensive emergency pharmacy services at Yale New Haven Hospital- Saint Raphael Campus. In 2011, he took an academic position at the College of Pharmacy.  For the past 6 years, Dr. Sun has been delivering presentations at pharmacy and emergency medicine conferences both within and outside of the United States. He speaks on topics ranging from pharmacy service in emergency care to pharmacy education.  He was awarded four educational grants on drug overdose and enhancing medication safety education ($56,000.00 total), and was the recipient of the College of Pharmacy Excellence in Scholarship award in 2014. 

Dr. Sun is currently serving as an Associate Editor to Drug Evaluation, a Chinese pharmacy journal. He is also a member of the Executive Committee of Chinese Pharmacological Society, Division of Therapeutic Drug Monitoring Research.
 

Teaching

  • PHAR 621 Renal Pharmacotherapy
  • PHAR 622 Respiratory Pharmacotherapy
  • PHAR 624 Cardiovascular Pharmacotherapy II
  • PHAR 727 Patient Care Management
  • PHAR 657 Management of Acute Overdose and Poisoning
     

Research/Scholarship

Dr Sun's current research focuses on emergency care, therapeutic drug monitoring, drug overdose, medication safety and global pharmacy education
 

Recent Publications

  1. Li XG, Ma N, Sun SS, Xu Z, Li W, Wang YJ, Yang X, Miao ZR, Zhao ZG. Association of genetic variant and platelet function in patients undergoing neuroendovascular stenting. Postgrad Med J. 2017 Mar 9. pii: postgradmedj-2016-134745. doi: 10.1136/postgradmedj-2016-134745. [Epub ahead of print] PubMed PMID: 28280103.

  2. Li X, Wu Y, Sun S, Zhao Z, Wang Q. Population Pharmacokinetics of Vancomycin in Postoperative Neurosurgical Patients and the Application in Dosing Recommendation.J Pharm Sci. 2016 Nov;105(11):3425-3431. doi: 10.1016/j.xphs.2016.08.012. PubMed PMID: 27671237.

  3. Zhao Z, Li X, Sun S, Mei S, Ma N, Miao Z, Zhao M, Peng S. Impact of genetic polymorphisms related to clopidogrel or acetylsalicylic acid pharmacology on clinical outcome in Chinese patients with symptomatic extracranial or intracranial stenosis.Eur J Clin Pharmacol. 2016 Oct;72(10):1195-204. doi: 10.1007/s00228-016-2094-1. PubMed PMID: 27450232.

  4. Li XG, Ma N, Wang B, Li XQ, Mei SH, Zhao K, Wang YJ, Li W, Zhao ZG, Sun SS, Miao ZR. The impact of P2Y12 promoter DNA methylation on the recurrence of ischemic events in Chinese patients with ischemic cerebrovascular disease.Sci Rep. 2016 Sep 30;6:34570. doi: 10.1038/srep34570. PubMed PMID: 27686864; PubMed Central PMCID: PMC5043343.

  5. Li XQ, Ma N, Li XG, Wang B, Sun SS, Gao F, Mo DP, Song LG, Sun X, Liu L, Zhao XQ, Wang YL, Wang YJ, Zhao ZG, Miao ZR. Association of PON1, P2Y12 and COX1 with Recurrent Ischemic Events in Patients with Extracranial or Intracranial Stenting.PLoS One. 2016 Feb 12;11(2):e0148891. doi: 10.1371/journal.pone.0148891. PubMed PMID: 26870959; PubMed Central PMCID: PMC4752331.

  6. Yi ZM, Sun SS, Li XX, Lu M, Zhai SD. An evaluation of clinical pharmacist service on a neurology care unit.Int J Clin Pharm. 2016 Feb;38(1):30-3. doi: 10.1007/s11096-015-0224-y. PubMed PMID: 26659084.

  7. Li X, Wu Y, Sun S, Mei S, Wang J, Wang Q, Zhao Z. Population Pharmacokinetics of Vancomycin in Postoperative Neurosurgical Patients.J Pharm Sci. 2015 Nov;104(11):3960-7. doi: 10.1002/jps.24604. PubMed PMID: 26239933.

  8. Yi ZM, Zhi XJ, Yang L, Sun SS, Zhang Z, Sun ZM, Zhai SD. Identify practice gaps in medication education through surveys to patients and physicians.Patient Prefer Adherence. 2015 Oct 9;9:1423-30. doi: 10.2147/PPA.S93219. PubMed PMID: 26557752; PubMed Central PMCID: PMC4624057.

  9. Sun S, Zimmermann AE. Cannabinoid hyperemesis syndrome.Hosp Pharm. 2013 Sep;48(8):650-5. doi: 10.1310/hpj4808-650. PubMed PMID: 24421535; PubMed Central PMCID: PMC3847982.

  10. Sun S, Zhao ZG. Updates of new molecular entities approved by the FDA in the first-half of 2016: Cancer, rare disease and anti-viral medications. Drug Evaluation 2016;13(16): 7-12 (in Chinese)

  11. Zhang LL, Sun S. Chapter 10: Pharmaceutical Care in Special Population: in Overview of Pharmaceutical Care. People's Medical Publishing House, Beijing, China, April, 2016. (Chinese Pharmacy Textbook)

  12. Zhang LL, Sun S. Chapter 13: Drug-Use Evaluation and Research Methods: in Overview of Pharmaceutical Care. People's Medical Publishing House, Beijing, China, April, 2016. (Chinese Pharmacy Textbook)

  13. Sun S, Zhao ZG. Clinical pharmacists in the management of drug overdose: opioids. Drug Evaluation 2016;13(6):8-11. (in Chinese)

  14. Sun S, Nemec E. Implementing an elective toxicology course through integration of emergency medicine resident physicians into didactic lectures. Currents in Pharmacy Teaching and Learning, 2016(8):200-206.

  15. Doyle-Campbell C, Ostroff J, Mattison M, Sun S. Patient care management: a comprehensive capstone course focusing on simulation in community, ambulatory and acute care. Currents in Pharmacy Teaching and Learning, 2016; 8:69-76.

  16. Sun S, Zhao ZG. Updates of new molecular entities approved by the FDA in the second-half of 2015: Respiratory, hematology, metabolic diseases and antidotes. Drug Evaluation 2016;13(4):12-19. (in Chinese)

  17. Sun S, Zhao Z. Clinical pharmacists in the management of drug overdose: sedative-hypnotic and antipsychotic drugs. Drug Evaluation 2016;13(2):8-16. (in Chinese)

  18. Sun S, Zhao Z. Updates of new molecular entities approved by the FDA in the second-half of 2015: cardiovascular, psychiatric, anti-viral, hypoactive sexual desire disorder, diabetes and chemotherapy-induced emesis. Drug Evaluation 2016;13(2):20-28. (in Chinese)

  19. Sun S, Zhao Z. Clinical pharmacists in the management of drug overdose: principles of patient management. Drug Evaluation 2015;12(24):23-26. (in Chinese)

  20. Sun S, Zhao Z. Potentially inappropriate medication use in older adults: 2015 Beers Criteria. Drug Evaluation, 2015;12(24):15-22. (in Chinese)

  21. Sun S, Zhao Z. Clinical pharmacists in the management of drug overdose: vital signs and toxidromes. Drug Evaluation 2015;12(22):6-13. (in Chinese)

  22. Sun S, Han R, Zhao Z. Updates of new molecular entities approved by FDA in first-half of 2015:Cardiovascular and Cancer Drugs. Drug Evaluation, 2015;12(16):6-12. (in Chinese)

  23. Sun S, Han R, Zhao Z. Updates of new molecular entities approved by FDA in first-half of 2015: gastrointestinal, dermatology, infectious and rare diseases. Drug Evaluation, 2015;12(14):5-10. (in Chinese)

  24. Sun S, Li X, Han R, Zhao Z. Updates of new molecular entities approved by FDA in 2014: Cancer Drugs. Drug Evaluation, 2015;12(10):6-12. (in Chinese)

  25. Sun S, Han R, Zhao Z. Updates of new molecular entities approved by FDA in 2014: gastrointestinal, neurological, psoriasis, rare diseases and imaging agents. Drug Evaluation, 2015;12(6):6-12. (in Chinese)

  26. Sun S, Ma X, Zhao Z. Updates of new molecular entities approved by FDA in 2014: cardiovascular, pulmonary and diabetic Drugs. Drug Evaluation, 2015;12(4):5-10. (in Chinese)

  27. Guo M, Zhao Z, Sun S, Li X. The comparison between novel oral anticoagulants and warfarin in clinical application.  Drug Evaluation, 2015;12(4):24-27. (in Chinese)

  28. Sun S, Li X, Han R, Zhao Z. Updates of new molecular entities approved by FDA in 2014: Infections and Infectious Disease. Drug Evaluation, 2015;12(2):8-14. (in Chinese)

  29. Thomas M, Sun S. Advanced pharmacy practice experiences for pharmacy students in emergency department settings. Currents in Pharmacy Teaching and Learning, 2015;7(3):378-381.

  30. Sun S, Nemec E, Tessier E, Joyce B. Implementing a learner-centered introductory pharmacy practice experience model at a community hospital. Currents in Pharmacy Teaching and Learning, 2015;7(2):231-238.

  31. Sun S. Chapter 1 Current State of Overdose: in Acute Poisoning and Rescue. People's Medical Publishing House, Beijing, China, May, 2015. (in Chinese)

  32. Sun S. Chapter 2 Patient Initial Assessment-Vital Signs and Toxidromes: in Acute Poisoning and Rescue. People's Medical Publishing House, Beijing, China, May, 2015. (in Chinese)

  33. Sun S. Chapter 3 Principles of Managing the Acutely Poisoned Patient: in Acute Poisoning and Rescue. People's Medical Publishing House, Beijing, China, May, 2015. (in Chinese)

  34. Sun S. Chapter 4 Antidotes and Their Appropriate Use: in Acute Poisoning and Rescue. People's Medical Publishing House, Beijing, China, May, 2015. (in Chinese)

  35. Sun S. Chapter 5 Appropriate Antidote Stock in Hospitals: in Acute Poisoning and Rescue. People's Medical Publishing House, Beijing, China, May, 2015. (in Chinese)

  36. Sun S, Si Y, Zhao Z. Introduction to the US expert guidelines for stocking antidotes in hospitals.  Drug Evaluation. 2014;11(22): 11-13. (in Chinese)

  37. Sun S, Xi H, Ma X, Zhao Z. Introduction to the Board of Pharmacy Specialty Certification Program in the United States and its rRevelation for China. Drug Evaluation. 2014;11(20):8-12. (in Chinese)


Professional Affiliations

  • American Society of Health-System Pharmacists (ASHP)
  • Society of Critical Care Medicine (SSCM)
  • American Association of Colleges of Pharmacy (AACP)
  • Chinese Pharmacological Society-Division of Therapeutic Drug Monitoring
     

Practice Area

   Holyoke Medical Center
   Focus: Emergency care